Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02487966 · ClinicalTrials.gov registry record · NA

Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)

A NA study of Phantom Limb Pain and Amputation, Traumatic, sponsored by Spaulding Rehabilitation Hospital.

Active
Registry status
NA
Development phase
132
Enrollment target
2
Study locations

NCT02487966: Active NA study of Phantom Limb Pain and Amputation, Traumatic, sponsored by Spaulding Rehabilitation Hospital.

NCT02487966 is a NA study of Phantom Limb Pain and Amputation, Traumatic that is active but no longer recruiting, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 132 participants, above the 112-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (18% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02487966, a NA study of Phantom Limb Pain and Amputation, Traumatic, is active but no longer recruiting, sponsored by Spaulding Rehabilitation Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
132 participants
Enrollment target
2
Study locations

Study Summary

This is a two-site study that explores the effects of mirror therapy and transcranial Direct Current Stimulation (tDCS, Soterix ©) in a randomized factorial controlled trial in which patients will be assigned to one of four groups: active tDCS and active MT; sham tDCS and active MT; active tDCS and sham MT (which consists of using a covered mirror for the therapy); and both sham tDCS and sham MT (covered mirror).

Primary Outcome

The primary endpoint will be the severity of pain measured by changes in PLP from baseline to 4 weeks (value at 4 weeks minus value at baseline), as indexed by a Visual Analog Scale (VAS). The VAS pain scale is a simple 10- point scale (0 = ''no pain'', 10 = ''pain as bad as you can imagine''). Since we are using a difference, smaller values (negative) represent a better outcome.

Interventions

  • DEVICE transcranial Direct Current Stimulation (tDCS): active (Soterix ©)
  • BEHAVIORAL Mirror Therapy: active
  • DEVICE transcranial Direct Current Stimulation (tDCS): sham (Soterix ©)
  • BEHAVIORAL Mirror Therapy: Sham

Study Locations (2)

Massachusetts

  • Spaulding Rehabilitation Network Research Institute - Charlestown

Other

  • IMREA HCFMUSP - Rede Lucy Montoro - São Paulo

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2015-07
Est. Completion 2026-12-21
Phase NA
Spaulding Rehabilitation Hospital

101 total trials

What the registry record for NCT02487966 still lists

NCT02487966 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, above the 112-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (18% higher).

The record links to 2 conditions, with Phantom Limb Pain appearing as the primary indexed condition, and to 4 interventions - of which transcranial Direct Current Stimulation (tDCS): active (Soterix ©) is the first listed.

NCT02487966 reports a single indexed study location in Massachusetts, Other.

Frequently Asked Questions

What is clinical trial NCT02487966 about?

NCT02487966 is a clinical study titled "Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)". This is a two-site study that explores the effects of mirror therapy and transcranial Direct Current Stimulation (tDCS, Soterix ©) in a randomized factorial controlled trial in which patients will be assigned to one of four groups: active tDCS and active MT; sham tDCS and active MT; active tDCS and ...

What is the current status of trial NCT02487966?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2015-07. Estimated completion is 2026-12-21.

What conditions does trial NCT02487966 study?

This clinical trial studies the following conditions: Phantom Limb Pain, Amputation, Traumatic.

What interventions are being tested in trial NCT02487966?

The interventions under investigation include: transcranial Direct Current Stimulation (tDCS): active (Soterix ©) (DEVICE), Mirror Therapy: active (BEHAVIORAL), transcranial Direct Current Stimulation (tDCS): sham (Soterix ©) (DEVICE), Mirror Therapy: Sham (BEHAVIORAL).

Who is sponsoring clinical trial NCT02487966?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02487966 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02487966's enrollment target sits among peer trials

132 4th of 12 higher than 9 of 12 other Phantom Limb Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phantom Limb Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01766297 · 132 participants · Phase 2

    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • NCT04002947 · 132 participants · Phase 2

    Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

  • NCT04128189 · 132 participants · Phase 3

    Shingrix in Renal Transplant Recipients

  • NCT04199780 · 132 participants · NA

    Effects of tDCS Combined With CBI on Postsurgical Pain

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02487966, the US trial registry maintained by the National Library of Medicine. NCT02487966 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.